Overview of Upixon
This section defines the fundamental identity, composition, and general purpose of Upixon (Pyrantel Pamoate), strictly excluding details on dosage, usage, side effects, or specific conditions it treats.
| Property | Description |
|---|---|
| Active ingredient | Pyrantel Pamoate |
| Forms | Oral Suspension, Tablet, Chewable Tablet |
| Pharmacological Class | Anthelmintic, Antinematodal |
| General Purpose | Management of intestinal parasitic worms |
| Origin | Synthetic, Pyrimidine-derivative |
What Type of Medicine is Upixon?
Upixon is a medicine whose active component is the established compound Pyrantel Pamoate, which is pharmacologically classified as an anthelmintic agent. It belongs to the specific category of antinematodal drugs, meaning it is synthesized for the targeted management of parasitic roundworm infestations in the intestines.
Upixon's therapeutic efficacy stems directly from the synthetic pyrimidine-derivative compound, Pyrantel. The compound is primarily administered as the Pamoate salt, a form deliberately chosen because of its poor absorption profile across the wall of the gastrointestinal tract. This characteristic ensures the highest concentration of the active medicine remains localized within the gut, where the parasitic worms reside, maximizing its therapeutic effect directly at the site of the infestation.
Composition and Available Forms of Upixon
The primary composition of the medicine is centered on the single active ingredient, Pyrantel Pamoate, combined with an inert aqueous vehicle or a solid excipient base. This medicine is designed exclusively for the oral route of administration and is commonly presented in two main forms. These pharmaceutical presentations include a liquid preparation known as Oral Suspension, which is typically beneficial for children or patients who may experience difficulty swallowing solid medications, and a solid dose form, such as the Tablet or Chewable Tablet.
General Purpose: How Pyrantel Works to Address Infestations
The general purpose of Pyrantel is to clear the intestinal tract of susceptible parasitic worms by swiftly rendering them immobile, allowing the body to naturally expel the infestation. This rapid action is achieved because the compound functions as a depolarizing neuromuscular blocking agent specific to the parasite. This mechanism induces immediate and irreversible spastic paralysis in the parasitic organisms, which prevents them from anchoring themselves to the intestinal wall. By halting their mobility, the medicine enables the body’s normal intestinal muscular movements, known as peristalsis, to effectively facilitate the expulsion of the paralyzed worms via defecation.
Regulatory References
